Analysis of the epidemiological situation on COVID-19
https://doi.org/10.25789/YMJ.2020.71.17
Abstract
The epidemiological situation of the new coronavirus infection COVID-19 in a number of countries, RF and the Republic of Sakha (Yakutia) has been studied. Three zones of the spread of the new coronavirus infection were conditionally identified: "red", "yellow", "green", which include countries with high, medium and favorable rates of spread. There were analyzed the prevalence, morbidity, mortality and lethality, dependence of the detection of new cases on the level of average air temperature.
About the Authors
T. E. Popova
СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
O. G. Tikhonova
ЯНЦ КМП
Russian Federation
Russian Federation
A. N. Romanova
ЯНЦ КМП
Russian Federation
Russian Federation
A. A. Tappakhov
ЯНЦ КМП;
СВФУ им. М.К. Аммосова;
УНЛ Клиники СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
M. E. Andreev
УНЛ Клиники СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
References
1. COVID-19 - a new global threat to humanity / N.Yu. Pshenichnaya, E.I. Veselova, D.A. Semenova [et al.] // Epidemiology and infectious diseases: topical issues. – 2020. – № 1. – Р. 6-13. DOI: https://dx.doi.org/10.18565/epidem.2020.10.1.6-13
2. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet / M. Gupte, C.M. Boustany-Kari, K. Bharadwaj [et al.]. // Am. J. Physiol. Regul. Integr. Comp. Physiol. – 2008. – 295 (3). – Р. 781-788. DOI: 10.1152/ajpregu.00183.2008.
3. Adult haemophagocytic syndrome / M. Ramos-Casals, P. Brito-Zeron, A. Lopez-Guillermo [et al.] // Lancet. – 2014. – 383. – Р. 1503-1516. DOI: 10.1016/S0140-6736(13)61048-X.
4. A new coronavirus associated with human respiratory disease in China / F. Wu, S. Zhao, B. Yu [et al.] // Nature. – 2020. – 579 (7798). – Р. 265-269. DOI: 10.1038/s41586-020-2008-3.
5. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis / A.J. Flammer, I. Sudano, F. Hermann [et al.] // Circulation. – 2008. – 117 (17). – Р. 2262-2269. DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.107.734384
6. A novel coronavirus from patients with pneumonia in China, 2019 / N. Zhu, D. Zhang, W. Wang [et al.] // N. Engl. J. Med. – 2020. – 382. – Р. 727-733. DOI: 10.1056/NEJMoa2001017.
7. A novel coronavirus outbreak of global health concern / C. Wang, P.W. Horby, F.G. Hayden, G.F. Gao // Lancet. – 2020. – 395 (10223). – Р. 470-473. DOI: https://doi.org/10.1016/S0140-6736(20)30185-9.
8. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis / D. Hurlimann, A. Forster, G. Noll [et al.]. // Circulation. – 2002. – 106. – Р. 2184- 2187. DOI: 10.1161/01.cir.0000037521.71373.44
9. A pneumonia outbreak associated with a new coronavirus of probable bat origin. P. Zhou, X.L. Yang, X.G. Wang [et al.]. // Nature. – 2020. – 579 (7798). – Р. 270-273. DOI: 10.1038/s41586-020-2012-7.
10. Characteristics of the life cycle of porcine deltacoronavirus (PDCoV) in vitro: replication kinetics, cellular ultrastructure and virion morphology, and evidence of inducing autophagy / P. Qin, E.Z. Du, W.T. Luo [et al.] // Viruses. – 2019. – 11 (5). – Р. 455. DOI: https://doi.org/10.3390/v11050455.
11. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China / C. Huang, Y. Wang, X. Li [et al.] // The Lancet. – 2020. – 395(10223). – Р. 497–506. DOI: https://doi.org/10.1016/S0140-6736(20) 30183-5.
12. COVID-19: consider cytokine storm syndromes and immunosuppression / P. Mehta, D.F. McAuley, M. Brown [et al.] // Lancet. – 2020. – 395(10229). – Р.1033-1034. DOI: 10.1016/S0140-6736(20)30628-0.
13. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients / S. Taddei, A. Virdis, L. Ghiadoni [et al.] // A. J Hypertens. – 1998. – 16. – Р. 447-456. DOI:10.1097/00004872-199816040-00006
14. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries / Y. Wu, W. Jing, J. Liu [et al.] // Sci Total Environ. – 2020. –729. – Р. 139051. DOI: 10.1016/j.scitotenv.2020.139051
15. Endothelial cell infection and endotheliitis in COVID-19 / Z. Varga, A.J. Flammer, P. Steiger [et al.] // The Lancet. – 2020. – 395 (10234). – P. 1417-1418. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5
16. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding / R. Lu, X. Zhao, J.Li [et al.] // The Lancet. – 2020. – 395. – Р. 565–74. DOI: https://doi.org/10.1016/S0140- 6736(20)30251-8.
17. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China / J. Liu , J. Zhou , J. Yao [et al.] // Sci Total Environ. – 2020. – 726. – Р. 138513. DOI: 10.1016/j.scitotenv.2020.138513.
18. Li F. Structure, function, and evolution of coronavirus spike proteins. / F. Li // Ann. Rev. Virol. – 2016. – 3 (1). – Р. 237-261. DOI: 10.1146/ annurev-virology-110615-042301.
19. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications / F. Wu, A. Wang, M. Liu [et al.] // medRxiv. – 2020. DOI: 10.1101/2020.03.30.20047365.
20. Qinfen Z. The life cycle of SARS coronavirus in Vero E6 cells / Z. Qinfen // J. Med. Virol. – 2004. – 73 (3). – Р. 332-337. DOI: 10.1002/jmv.20095
21. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) / J. Fang, L. Deng, L. Zhang [et al.] // J. Gen. Intern. Med. – 2020. – 35 (10223). – Р. 1545-1549. DOI: 10.1007/s11606-020-05762-w
22. Su Z., Wu Y. A multiscale and comparative model for receptor binding of 2019 novel coronavirus and the implications of its life cycle in host cells / Z. Su, Y.Wu // BioRxiv. – 2020. DOI: https://doi.org/10.1101/2020.02.20.958272
23. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion / T.J. Anderson, I.T. Meredith, A.C. Yeung [et al.] // Engl J Med. – 1995. – 332. – Р. 488-493. DOI: 10.1056/NEJM199502233320802.
24. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed / M. Feldmann, R.N. Maini, J.N. Woody [et al.] // Lancet. – 2020. – 395 (10234). – Р. 1407-1409. https://doi.org/10.1016/S0140-6736(20)30858-8.
25. Turner A.J. ACE2: from vasopeptidase to SARS virus receptor / A.J. Turner, J.A. Hiscox, N.M. Hooper // Trends Pharmacol. Sci. – 2004. – 25 (6). – Р. 291-294. DOI: 10.1016/j.tips.2004.04.001.
26. 1.000.000 cases of COVID-19 outside of China: The date predicted by a simple heuristic / W.W. Koczkodaj, M.A. Mansournia, W. Pedrycz [et al.] // Glob Epidemiol. – 2020. – 23. – Р. 100023. DOI: 10.1016/j.gloepi.2020.100023
27. https://covid19.who.int/region
28. https://www.who.int/ru/news-room/detail/08-04-2020-who-timeline---covid-19
29. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
30. https://who.maps.arcgis.com/apps/opsdashboard/index.html#/a19d5d1f86ee4d99b013eed5f637232d
31. https://www.worldometers.info/coronavirus/country/italy/
Review
For citations:
Popova T.E., Tikhonova O.G., Romanova A.N., Tappakhov A.A., Andreev M.E. Analysis of the epidemiological situation on COVID-19. Yakut Medical Journal. 2020;(3):63-67. (In Russ.) https://doi.org/10.25789/YMJ.2020.71.17
Views:
12
Email this article 